Literature DB >> 158971

Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy?

E D Frohlich, R C Tarazi.   

Abstract

Increased arterial pressure is obviously the major stimulus to cardiac hypertrophy in hypertension. However, different studies suggest that in addition to the pressure load, other factors could play participating roles in determining the degree of ventricular hypertrophy in response to the hypertensive disease as well as the degree of its reversal after control of arterial pressure. These other mechanisms include genetic factors and concimitant processes such as aging and the presence of cardiomyopathy or other disease. Two neurohumoral influences, namely, the adrenergic and the renin-angiotensin systems, may also participate, and the early evidence supporting these possible contributing factors is cited. Further studies are needed to determine the relative importance of each of these factors in different types of hypertension and in their response to different modes of antihypertensive therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 158971     DOI: 10.1016/0002-9149(79)90229-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

2.  Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.

Authors:  T Natsume; M B Kardon; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

3.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

4.  Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.

Authors:  C A Feldstein; A O Olivieri; R P Sabarís
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Correction of physiological alterations of hypertension.

Authors:  E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

6.  Control of blood pressure and reduction of echocardiographically assessed left ventricular mass with one-daily timolol.

Authors:  D B Rowlands; D R Glover; T J Stallard; W A Littler
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

Review 7.  Effects of different antihypertensive drugs on left ventricular function.

Authors:  R Oliveri
Journal:  Drugs       Date:  1988       Impact factor: 9.546

8.  Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study.

Authors:  H G Kirpizidis; G S Papazachariou
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

9.  Birth weight, weight at one year, and left ventricular mass in adult life.

Authors:  M Vijayakumar; C H Fall; C Osmond; D J Barker
Journal:  Br Heart J       Date:  1995-04

10.  Left ventricular hypertrophy regression during antihypertensive treatment.

Authors:  H Eichstaedt; O Danne; R J Schroeder; D Kreuz
Journal:  Clin Investig       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.